Engineering of a novel thioether bridge and role of modified residues in the lantibiotic Pep5

Applied and Environmental Microbiology

Volumn 62, Issue 2, 1996, Pages 385-392

  Bierbaum, Gabriele ^a   Szekat, Christiane ^a   Josten, Michaele ^a   Heidrich, Christoph ^a   Kempter, Christoph ^b   Jung, Gunther ^b   Sahl, Hans Georg ^a  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; BUTYRIC ACID DERIVATIVE; DIDEHYDROBUTYRINE; LANTHIONINE; LANTIBIOTIC; METHYLLANTHIONINE; MUTANT PROTEIN; OXOBUTYRINE; SULFIDE; SULFUR AMINO ACID; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ANTIMICROBIAL ACTIVITY; ARTICLE; BACILLUS SUBTILIS; CONTROLLED STUDY; DRUG STRUCTURE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; SITE DIRECTED MUTAGENESIS; STAPHYLOCOCCUS EPIDERMIDIS;

EID: 0030046024     PISSN: 00992240     EISSN: None     Source Type: Journal    
DOI: 10.1128/aem.62.2.385-392.1996     Document Type: Article

References (41)

1. Augustin, J., and F. Götz. 1990. Transformation of Staphylococcus epidermidis and other staphylococcal species with plasmid DNA by electroporation FEMS Microbiol. Lett. 66:203-208
2. Augustin, J., R. Rosenstein, B. Wieland, U. Schneider, N. Schnell, G. Engelke, K.-D. Entian, and F. Götz. 1992. Genetic analysis of epidermin biosynthetic genes and epidermin-negative mutants of Staphylococcus epidermidis. Eur J. Biochem 204:1149-1154.
3. Bierbaum, G., M. Reis, C. Szekat, and H.-G. Sahl. 1994. Construction of an expression system for engineering of the lantibiotic Pep5 Appl. Environ. Microbiol. 60:4332-4338.
4. Bierbaum, G., and H.-G. Sahl. 1987. Autolytic system of Staphylococcus simulans 22: influence of cationic peptides on activity of N-acetylmuramoyl-L-alanine amidase. J. Bacteriol. 169:5452-5458.
5. Bisschop, A., and W. N. Konings. 1976. Reconstitution of reduced nicotinamide adenine dinucleotide oxidase activity with menadione in membrane vesicles from the menaquinone-deficient Bacillus subtilis AroD Relation between electron transfer and active transport. Eur. J. Biochem. 67:357-365.
6. Boman, H. G., J. Marsh, and J. A. Goode. 1994. Antimicrobial peptides. John Wiley & Sons, Ltd., Chichester, England.
7. De Vuyst, L., and E. J. Vandamme. 1994. Nisin, a lantibiotic produced by Lactococcus lactis subsp lactis: properties, biosynthesis, fermentation and applications, p. 151-220. In L. de Vuyst and E. J. Vandamme (ed ), Bacteriocins of lactic acid bacteria: microbiology, genetics and applications. Blackie Academic & Professional, London.
8. Dodd, H. M., and M. J. Gasson. 1994. Bacteriocins of lactic acid bacteria, p. 211-251. In M. J. Gasson and W. M. de Vos (ed ), Genetics and biotechnology of lactic acid bacteria. Chapman & Hall, London.
9. Driessen, A. J. M., H. W. van den Hooven, W. Kuiper, M. van de Kamp, H.-G. Sahl, R. N. H. Konings, and W. N. Konings. 1995. Mechanistic studies of lantibiotic-induced permeabilization of phospholipid vesicles. Biochemistry 34:1606-1614.
10. Ersfeld-Dressen, H., H.-G. Sahl, and H. Brandis. 1984. Plasmid involvement in production of and immunity to the staphylococcin-like peptide Pep5. J. Gen. Microbiol. 130:3029-3035
11. Freund, S., G. Jung, W. A. Gibbons, and H.-G. Sahl. 1991 NMR and circular dichroism studies on Pep5, p. 103-112. In G. Jung and H.-G. Sahl (ed ), Nisin and novel lantibiotics. Escom, Leiden, The Netherlands
12. Freund, S., G. Jung, O. Gutbrod, G. Folkers, W. A. Gibbons, H. Allgaier, and R. Werner. 1991 The solution structure of the lantibiotic gallidermin. Biopolymers 31:803-811.
13. Götz, F., and B. Schumacher. 1987 Improvements of protoplast transformation in Staphylococcus carnosus. FEMS Microbiol. Lett. 40:285-288.
14. Gross, E., and J, L. Morell. 1971. The structure of nisin J. Am. Chem. Soc. 93:4634-4635
15. Jung, G. 1991. Lantibiotics - ribosomally synthesized biologically active polypeptides containing sulfide bridges and α,β-didehydroamino acids. Angew Chem Int Ed. Engl. 30:1051-1068.
16. Kaletta, C., K.-D. Entian, R. Kellner, G. Jung, M. Reis, and H.-G. Sahl. 1989. Pep5, a new lantibiotic: structural gene isolation and prepeptide sequence. Arch. Microbiol. 152:16-19.
17. Kellner, R., G. Jung, M. Josten, C. Kaletta, K.-D. Entian, and H.-G. Sahl. 1989. Pep5: structure elucidation of a large lantibiotic. Angew. Chemie Int. Ed. Engl. 28:616-619
18. Kordel, M., R. Benz, and H.-G. Sahl. 1988. Mode of action of the staphyloccocinlike peptide Pep 5: voltage-dependent depolarization of bacterial and artificial membranes J Bacteriol. 170:84-88.
19. Kuipers, O. P., H. S. Rollema, W. M. G. J. Yap, H. J. Boot, R. J. Siezen, and W. M. de Vos. 1992 Engineering dehydrated amino acid residues in the antimicrobial peptide nisin. J. Biol. Chem. 267:24340-24346.
20. Kupke, T., C. Kempter, G. Jung, and F. Götz. 1995. Oxidative decarboxylation of peptides catalyzed by flavoprotein EpiD Determination of substrate specificity using peptide libraries and neutral loss mass spectrometry J. Biol. Chem. 270:11282-11289
21. Kupke, T., S. Stevanovic, H.-G. Sahl, and F. Götz. 1992. Purification and characterization of EpiD, a flavoprotein involved in the biosynthesis of the lantibiotic epidermin. J Bacteriol. 174:5354-5361.
22. Liu, W., and J. N. Hansen. 1993 The antimicrobial effect of a structural variant of subtilin against outgrowing Bacillus cereus T spores and vegetative cells occurs by different mechanisms. Appl. Environ. Microbiol. 59:648-651
23. Maloy, W. L., and U. P. Kari. 1995. Structure-activity studies on magainins and other host defense peptides. Biopolymers 37:105-122.
24. Meyer, C., G. Bierbaum, C. Heidrich, M. Reis, J. Süling, M. I. Iglesias-Wind, C. Kempter, E. Molitor, and H.-G. Sahl. 1995. Nucleotide sequence of the lantibiotic Pep5 biosynthetic gene cluster and functional analysis of PepP and PepC: evidence for a role of PepC in thioether formation. Eur. J. Biochem. 232: 478-489
25. Ojeius, D. M., and J. D.-E. Young. 1991. Cytolytic pore-forming proteins and peptides, is there a common structural motif? Trends Biochem. Sci. 16:225-229.
26. Ottenwälder, B., T. Kupke, S. Brecht, V. Gnau, J. Metzger, G. Jung, and F. Götz. 1995. Isolation and characterization of genetically engineered gallidermin and epidermin analogs. Appl. Environ. Microbiol. 61:3894-3903.
27. Reis, M., M. Eschbach-Bludau, M. I. Iglesias-Wind, T. Kupke, and H.-G. Sahl. 1994. Producer immunity towards the lantibiotic Pep5: identification of the immunity gene pepl and localization and functional analysis of its gene product. Appl. Environ. Microbiol. 60:2876-2883.
28. Sahl, H.-G. 1991. Pore formation in bacterial membranes by cationic lantibiotics, p. 347-358. In G. Jung and H.-G Sahl (ed.), Nisin and novel lantibiotics. Escom, Leiden, The Netherlands.
29. Sahl, H.-G., and H. Brandis. 1981. Production, purification and chemical properties of an antistaphylococcal agent produced by Staphylococcus epidermidis J Gen. Microbiol. 127:377-384
30. Sahl, H.-G., M. Grossgarten, W. R. Widger, W. A. Cramer, and H. Brandis. 1985. Structural similarities of the staphylococcin-like peptide Pep-5 to the peptide antibiotic nisin. Antimicrob. Agents Chemother. 27:836-840.
31. Sahl, H.-G., R. W. Jack, and G. Bierbaum. 1995. Biosynthesis and biological activities of lantibiotics with unique post-translational modifications Eur. J Biochem. 230:827-853.
32. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
33. Sanger, F., S. Nicklen, and A. R. Coulson. 1977. DNA sequencing with chain-terminating inhibitors. Prov. Natl Acad. Sci. USA 74:5463-5467
34. Schleifer, K. H., and U. Fischer. 1982. Description of a new species of the genus Staphylococcus: Staphylococcus carnosus. Int. J. Syst. Bacteriol. 32: 153-156.
35. Schnell, N., K.-D. Entian, U. Schneider, F. Götz, H. Zähner, R. Kellner, and G. Jung. 1988 Prepeptide sequence of epidermin, a ribosomally synthesized antibiotic with four sulphide rings. Nature (London) 333:276-278.
36. Vieira, J., and J. Messing. 1982. The pUC plasmids, an M13mp7-derived system for insertion mutagenesis and sequencing with synthetic universal primers. Gene 19:259-268
37. Vogel, H., L. Nilsson, R. Rigler, S. Meder, G. Boheim, W. Beck, H.-H. Kurth, and G. Jung. 1993. Structural fluctuations between two conformational states of a transmembrane helical peptide are related to its channel-forming properties in planar lipid membranes Eur. J. Biochem. 212:305-313.
38. Wade, D., D. Andreu, S. A. Mitchell, A. M. V. Silveira, A. Boman, H. G. Boman, and R. B. Merrifield. 1992. Antibacterial peptides designed as analogs or hybrids of cecropins and melittin. Int J. Pept. Protein Res. 40:429-436
39. Weil, H.-P., A. G. Beck-Sickinger, J. Metzger, S. Stevanovic, G. Jung, M. Josten, and H.-G. Sahl. 1990. Biosynthesis of the lantibiotic Pep5. Isolation and characterization of a prepeptide containing dehydroamino acids. Eur. J. Biochem. 194:217-223.
40. Yanisch-Perron, C., J. Vieira, and J. Messing. 1985. Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors. Gene 33:103-109.
41. Zell, R., and H. Fritz. 1987. DNA mismatch repair in Escherichia coli counteracting the hydrolytic deamination of 5-methyl-cytosine residues. EMBO J. 6:1809-1815.